BridgeMD
New treatment option for Haplo-identical Transplantation
Official title Psychological Impact of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation on Donors
ClinicalTrials.gov ID: NCT06089850
What this study is testing
- What it's testing
- Allogeneic hematopoietic stem cell transplantation (allo-HSC) is currently one of the only curative treatments for haematological malignancies with a poor prognosis, the realization of which presupposes the identification and availability of a compatible donor. In recent years, haploidentical transplants have been developed, a reliable alternative for patients who do not have 100% compatible donors.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Identical haplo CSH donors ascending (parents) or descending (children)
- Major identical haplo HSC donors
- Haplo-identical HSC donors living in mainland France and cared for in the centers participating in the study
- Haplo-identical HSC donors benefiting from Social Security System.
- Haplo-identical HSC donors who have signed the consent form
You likely can't join if
- \- Insufficient understanding of the French language
See the full eligibility criteria
- Identical haplo CSH donors ascending (parents) or descending (children)
- Major identical haplo HSC donors
- Haplo-identical HSC donors living in mainland France and cared for in the centers participating in the study
- Haplo-identical HSC donors benefiting from Social Security System.
- Haplo-identical HSC donors who have signed the consent form
- \- Ability to read and write in French
- \- Insufficient understanding of the French language
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.